… with 18 F-FDOPA PET is increasingly used for detection of glioblastoma recurrence. However,
a standardized image interpretation for 18 F-FDOPA brain PET studies has not yet been …

… BTV defined with 11C-MET PET included all localizations of … MET PET volumes appear to
identify areas at highest risk of recurrence for patients with glioblastomas since inadequate PET…

… the predictive value of PET using O-(2- 18 F-fluoroethyl)-l-tyrosine ( 18 F-FET PET) during …
study, 25 patients with glioblastoma were investigated by MRI and 18 F-FET PET after surgery (…

Glioblastoma (GB) is a highly heterogeneous tumor. In order to identify in vivo the most
malignant tumor areas, the extent of tumor infiltration and the sites giving origin to GB stem cells (…

… In this study, we explored the use of multi-parametric PET and MRI prior to radiotherapy
for the location of tumour recurrence after radiotherapy in glioblastoma patients. The site of …

… This review will discuss the PET imaging agents that have already been evaluated in GBM
patients so far, and new imaging targets with promise for future use. Previously used PET …

… delineated by amino acid PET and MRI in patients with newly diagnosed, untreated glioblastoma.
… [35] investigated the value of MET PET in comparison with conventional MRI for target …

… in GBM the sensitivity of 18 F-FDOPA PET/CT was higher than that of 18 F-FDG PET/CT (100
% vs. 90.9 %) but specificity was similar (100 %). In grade III glioma too, 18 F-FDOPA PET/…

… PET imaging with 18 F-GE-180 and MRI of patients with untreated and recurrent pretreated
glioblastoma… time TSPO PET imaging with 18 F-GE-180 and MRI in patients with untreated …

… survival in patients with suspected recurrent glioma after … , only one patient with a malignant
glioma was included. Our … -FCho PET for early therapy response assessment in GB patients; …